title: Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.
abstract: OBJECTIVE
  To investigate the clinical efficiency of percutaneous trans-hepatic bilateral biliary metallic stenting for the management of Bismuth IV malignant obstructive disease.
  
  
  METHODS
  Our hospital's database was searched for all patients suffering from the inoperable malignant biliary obstruction Bismuth IV, and treated with percutaneous bilateral trans-hepatic placement of self-expandable nitinol stents. The indication for percutaneous stenting was an inoperable, malignant, symptomatic, biliary obstruction. An un-correctable coagulation disorder was the only absolute contra-indication for treatment. Bismuth grading was performed using magnetic resonance cholangiopancreatography. Computed tomography evaluation of the lesion and the dilatation status of the biliary tree was always performed prior to the procedure. All procedures were performed under conscious sedation. A single trans-hepatic track technique was preferred (T-configuration stenting) and a second, contra-lateral trans-hepatic track (Y-configuration stenting) was used only in cases of inability to access the contra-lateral lobe using a single track technique. The study's primary endpoints were clinical success, defined as a decrease in bilirubin levels within 10 d and patient survival rates. Secondary endpoints included peri-procedural complications, primary and secondary patency rates.
  
  
  RESULTS
  A total of 35 patients (18 female, 51.4%) with a mean age 69 ± 13 years (range 33-88) were included in the study. The procedures were performed between March 2000 and June 2008 and mean time follow-up was 13.5 ± 22.0 mo (range 0-96). The underlying malignant disease was cholangiocarcinoma (n = 10), hepatocellular carcinoma (n = 9), pancreatic carcinoma (n = 5), gastric cancer (n = 2), bile duct tumor (n = 2), colorectal cancer (n = 2), gallbladder carcinoma (n = 2), lung cancer (n = 1), breast cancer (n = 1) or non-Hodgkin lymphoma (n = 1). In all cases, various self-expandable bare metal stents with diameters ranging from 7 to 10 mm were used. Stents were placed in Y-configuration in 24/35 cases (68.6%) using two stents in 12/24 patients and three stents in 12/24 cases (50%). A T-configuration stent placement was performed in 11/35 patients (31.4%), using two stents in 4/11 cases (36.4%) and three stents in 7/11 cases (63.6%). Follow-up was available in all patients (35/35). Patient survival ranged from 0 to 1763 d and the mean survival time was 168 d. Clinical success rate was 77.1% (27/35 cases), and peri-procedural mortality rate was 5.7% (2/35 patients). Biliary re-obstruction due to stent occlusion occurred in 25.7% of the cases (9/35 patients), while in 7/11 (63.6%) one additional percutaneous re-intervention due to stent occlusion resulting in clinical relapse of symptomatology was successfully performed. In the remaining 4/11 patients (36.4%) more than 1 additional reintervention was performed. The median decrease of total serum bilirubin was 60.5% and occurred in 81.8% of the cases (27/33 patients). The median primary and secondary patency was 105 (range 0-719) and 181 d (range 5-1763), respectively. According to the Kaplan-Meyer survival analysis, the estimated survival rate was 73.5%, 47.1% and 26.1% at 1, 6 and 12 mo respectively, while the 8-year survival rate was 4.9%. Major and minor complication rates were 5.7% (2/35 patients) and 17.1% (6/35 patients), respectively.
  
  
  CONCLUSIONS
  Percutaneous bilateral biliary stenting is a safe and clinically effective palliative approach in patients suffering from Bismuth IV malignant obstruction.
authors.affiliation: Dimitrios Karnabatidis, Stavros Spiliopoulos, Paraskevi Katsakiori, Odissefs Romanos, Konstantinos Katsanos, Dimitrios Siablis, Department of Interventional Radiology, Patras University Hospital, 26504 Patras, Greece.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Karnabatidis
authors.forename: Stavros
authors.initials: S
authors.lastname: Spiliopoulos
authors.forename: Paraskevi
authors.initials: P
authors.lastname: Katsakiori
authors.forename: Odissefs
authors.initials: O
authors.lastname: Romanos
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Katsanos
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Siablis
keywords: Bismuth IV; Fluoroscopically-guided; Malignant biliary obstruction; Nitinol stents; Palliative treatment; Percutaneous bilateral stenting
references.citation: Gastrointest Endosc. 2009 Jan;69(1):55-62
references.pmid: 18657806
references.citation: Cardiovasc Intervent Radiol. 2009 Jul;32(4):707-13
references.pmid: 19387728
references.citation: J Hepatobiliary Pancreat Surg. 2009;16(5):628-32
references.pmid: 19554255
references.citation: Radiology. 2002 Oct;225(1):35-42
references.pmid: 12354981
references.citation: Eur Radiol. 2008 Mar;18(3):448-56
references.pmid: 17960388
references.citation: World J Gastroenterol. 2007 Aug 7;13(29):3948-55
references.pmid: 17663508
references.citation: J Hepatobiliary Pancreat Surg. 2009;16(5):624-7
references.pmid: 19551332
references.citation: Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):66-73
references.pmid: 17031733
references.citation: J Vasc Interv Radiol. 2004 Jul;15(7):713-7
references.pmid: 15231885
references.citation: Tech Vasc Interv Radiol. 2001 Sep;4(3):147-52
references.pmid: 11748553
references.citation: Abdom Imaging. 2004 Sep-Oct;29(5):581-9
references.pmid: 15185022
references.citation: Hepatogastroenterology. 2000 Nov-Dec;47(36):1509-13
references.pmid: 11148989
references.citation: Medicina (Kaunas). 2008;44(12):969-76
references.pmid: 19142055
references.citation: Clin Gastroenterol Hepatol. 2008 Aug;6(8):944-950.e3
references.pmid: 18585976
references.citation: Radiology. 1990 Dec;177(3):789-92
references.pmid: 2243991
references.citation: J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):214-22
references.pmid: 22415652
references.citation: J Gastroenterol Hepatol. 2009 Apr;24(4):552-7
references.pmid: 19220678
references.citation: Radiology. 1989 Jan;170(1 Pt 1):191-4
references.pmid: 2909096
references.citation: J Vasc Interv Radiol. 2008 Nov;19(11):1614-9
references.pmid: 18823794
references.citation: Cardiovasc Intervent Radiol. 2011 Apr;34(2):352-61
references.pmid: 20467870
references.citation: J Vasc Interv Radiol. 2003 Nov;14(11):1409-16
references.pmid: 14605106
references.citation: Cardiovasc Intervent Radiol. 1994 May-Jun;17(3):127-32
references.pmid: 8087827
references.citation: HPB (Oxford). 2009 Jun;11(4):358-63
references.pmid: 19718365
references.citation: Radiology. 1990 Dec;177(3):793-7
references.pmid: 2173842
references.citation: Radiology. 2002 Oct;225(1):27-34
references.pmid: 12354980
references.citation: Tech Vasc Interv Radiol. 2008 Mar;11(1):43-50
references.pmid: 18725140
references.citation: Tech Vasc Interv Radiol. 2008 Mar;11(1):14-20
references.pmid: 18725138